Patents by Inventor Joerg Senn-Bilfinger

Joerg Senn-Bilfinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TETRAHYDROPYRIDOETHERS FOR TREATMENT OF AMD
    Publication number: 20220370425
    Abstract: A method is described in which treatment is carried out with compounds of tetrahydropyridoethers that are administered in form of a medication to treat AMD and to remove lipofuscin from a patient's eye.
    Type: Application
    Filed: July 14, 2022
    Publication date: November 24, 2022
    Applicants: Katairo GmbH, Takeda GmbH
    Inventors: Ulrich Schraermeyer, Jörg Senn-Bilfinger, Ernst Sturm
  • Methods for the determination of compounds or compositions for the treatment of lipofuscin related diseases and compounds or compositions
    Patent number: 10495630
    Abstract: A method for selecting a compound or a composition suitable for treating lipofuscin associated diseases in a patient, the method including the steps of determining a reactivity factor, determining a targeting factor that allows an uptake into a cell and a provides a targeting of lipofuscin, and selecting a compound or a composition or combining compounds to obtain a compound or composition that comprises a reactivity factor and an targeting factor.
    Type: Grant
    Filed: February 13, 2015
    Date of Patent: December 3, 2019
    Assignees: KATAIRO GMBH, TAKEDA GMBH
    Inventors: Ulrich Schraermeyer, Michael Burnet, Jörg Senn-Bilfinger, Ernst Sturm, Guido Hanauer
  • Tetrahydropyridoethers
    Patent number: 7393860
    Abstract: The compound (7R,8R,9R)-2,3-Dimethyl-8-hydroxy-7-(2-methoxyethoxy)-9-phenyl-7,8,9,10-tetrahydro-imidazo-[1,2-h] [1,7] naphthyridine inhibits the secretion of gastric acid.
    Type: Grant
    Filed: July 27, 2006
    Date of Patent: July 1, 2008
    Assignee: Altana Pharma AG
    Inventor: Jörg Senn-Bilfinger
  • 8-Substituted imidazopyridines
    Patent number: 7326718
    Abstract: The present invention relates to 8-substituted imidazopyridines of a certain formula (1) in which the substitutents and symbols have the meanings indicated in the description. The compounds have gastric secretion inhibiting and excellent gastric and intestinal protective action properties.
    Type: Grant
    Filed: November 15, 2003
    Date of Patent: February 5, 2008
    Assignee: Altana Pharma AG
    Inventors: Wilm Buhr, Jörg Senn-Bilfinger, Peter Jan Zimmermann
  • Tricyclic n-acyl compounds
    Patent number: 7314935
    Abstract: The invention relates to compounds of the formula (1) where the substituents and symbols are as defined in the description. The compounds are valuable intermediates for preparing active pharmaceutical ingredients.
    Type: Grant
    Filed: February 12, 2003
    Date of Patent: January 1, 2008
    Assignee: Altana Pharma AG
    Inventors: Wilm Buhr, Jörg Senn-Bilfinger, Peter Jan Zimmerman, Peter Zimmerman
  • Tricyclic imidazopyridines
    Patent number: 7223771
    Abstract: The invention provides compounds of the formula (I), in which the substituents and symbols are as defined in the description. The compounds inhibit the secretion of gastric acid.
    Type: Grant
    Filed: July 31, 2002
    Date of Patent: May 29, 2007
    Assignee: Altana Pharma AG
    Inventors: Wilm Buhr, Jörg Senn-Bilfinger
  • Prodrugs of imidazopyridine derivatives
    Patent number: 7189736
    Abstract: Compounds of formula 1, in which the substituents have the meanings mentioned in the description are suitable for the prevention and treatment of gastrointestinal diseases.
    Type: Grant
    Filed: April 19, 2004
    Date of Patent: March 13, 2007
    Assignee: Altana Pharma AG
    Inventors: Jörg Senn-Bilfinger, Wilm Buhr
  • Polysubstituted imidazopyridines as gastric secretion inhibitors
    Patent number: 7141567
    Abstract: The invention relates to imidazopyridines of a certain formula 1, in which the substituents and symbols have the meanings indicated in the description. The compounds have gastric secretion-inhibiting properties.
    Type: Grant
    Filed: May 24, 2004
    Date of Patent: November 28, 2006
    Assignee: Altana Pharma AG
    Inventors: Jörg Senn-Bilfinger, Wilm Buhr, Peter Zimmermann, Bernhard Kohl
  • Tetrahydropyridoethers
    Patent number: 7105676
    Abstract: Compounds of formula (1) in which the substituents have the meanings mentioned in the description, are suitable for the prevention and treatment of gastrointestinal diseases.
    Type: Grant
    Filed: February 23, 2004
    Date of Patent: September 12, 2006
    Assignee: Altana Pharma AG
    Inventor: Jörg Senn-Bilfinger
  • Combinations and use of selected pharmaceutically active compounds
    Publication number: 20060154954
    Abstract: The present invention relates to new combinations and new uses of certain selected tricyclic imidazo [1,2-a]pyridine compounds in the prevention or treatment of medicament caused gastrointestinal diseases.
    Type: Application
    Filed: February 16, 2004
    Publication date: July 13, 2006
    Applicant: ALTANA PHARMA AG
    Inventors: Wilm Buhr, Wolfgang Kromer, Peter Zimmermann, Andreas Palmer, Christof Brehm, Thomas Klein, Joerg Senn-Bilfinger, Wolfgang-Alexander Simon, Stefan Postius
  • 6-Substituted imidazopyrazines
    Publication number: 20060148796
    Abstract: The present invention relates to 6-substituted imidazopyrazines of formula 1 in which the substituents and symbols have the meanings indicated in the description. The compounds have gastric secretion inhibiting and excellent gastric and intestinal protective action properties.
    Type: Application
    Filed: February 16, 2004
    Publication date: July 6, 2006
    Inventors: Peter Zimmermann, Wilm Buhr, M. Chiesa, Andreas Palmer, Christof Brehm, Gerhard Grundler, Joerg Senn-Bilfinger, Wolfgang-Alexander Simon, Stefan Postius, Wolfgang Kromer
  • Process for the production of 3-phenylisoserine
    Patent number: 7034178
    Abstract: This invention is drawn to a process for the production of (R,R)-phenylisoserine or a 1–4C-alkyl ester thereof.
    Type: Grant
    Filed: June 27, 2002
    Date of Patent: April 25, 2006
    Assignee: Altana Pharma AG
    Inventors: Wijnand Faber, Jan Koek, Jörg Senn-Bilfinger, Ton Vries
  • Pyrano[2,3-C]imidazo[-1,2-A]pyridine derivatives for the treatment of gastrointestinal disorders
    Patent number: 6936623
    Abstract: Compounds of the formula (I), in which the substituents have the meanings mentioned in the description, are suitable for the prevention and treatment of gastrointestinal diseases.
    Type: Grant
    Filed: April 1, 2004
    Date of Patent: August 30, 2005
    Assignee: Altana Pharma AG
    Inventors: Jörg Senn-Bilfinger, Wilm Buhr
  • Tricyclic epoxides
    Patent number: 6927292
    Abstract: The invention relates to compounds of Formula (1), in which the substituents and symbols have the meanings indicated in the description. The compounds are valuable intermediates for the preparation of pharmaceutical active compounds.
    Type: Grant
    Filed: July 31, 2002
    Date of Patent: August 9, 2005
    Assignee: Altana Pharma AG
    Inventors: Jörg Senn-Bilfinger, Peter Jan Zimmermann
  • Alkylated imidazopyridine derivatives
    Patent number: 6916825
    Abstract: Compounds of the formula 1 in which the substituents have the meanings mentioned in the description are suitable for the prevention and treatment of gastrointestinal diseases.
    Type: Grant
    Filed: March 28, 2001
    Date of Patent: July 12, 2005
    Assignee: Altana Pharma AG
    Inventors: Jörg Senn-Bilfinger, Wilm Buhr
  • Polysubstituted imidazopyridines as gastric secretion inhibitors
    Patent number: 6869949
    Abstract: The invention relates to imidazopyridines of a certain formula 1, in which the substituents and symbols have the meanings indicated in the description. The compounds have gastric secretion-inhibiting properties.
    Type: Grant
    Filed: October 23, 2001
    Date of Patent: March 22, 2005
    Assignee: Altana Pharma AG
    Inventors: Jörg Senn-Bilfinger, Wilm Buhr, Peter Zimmermann, Bernhard Kohl
  • Process and intermediates for the preparation of imidazopyridines
    Patent number: 6812349
    Abstract: The invention relates to compounds of formula (2) in which R1, R2, R3 and R4 have the meanings indicated in the description, their preparation and their further reaction to give compounds of formula (1), in which A1, A2 and R4 have the meanings indicated in the description. The compounds of the formula (1) are valuable intermediates for the preparation of medicaments.
    Type: Grant
    Filed: September 23, 2003
    Date of Patent: November 2, 2004
    Assignee: Altana Pharma AG
    Inventors: Wolf-Rüdiger Ulrich, Christian Scheufler, Thomas Fuchss, Jörg Senn-Bilfinger
  • Process and intermediates for the preparation of imidazopyridines
    Patent number: 6716990
    Abstract: The invention relates to compounds of formula (2) in which R1, R2, R3 and R4 have the meanings indicated in the description, their preparation and their further reaction to give compounds of formula (1), in which A1, A2 and R4 have the meanings indicated in the description. The compounds of the formula (1) are valuable intermediates for the preparation of medicaments.
    Type: Grant
    Filed: June 11, 2002
    Date of Patent: April 6, 2004
    Assignee: Altana Pharma AG
    Inventors: Wolf-Rüdiger Ulrich, Christian Scheufler, Thomas Fuchss, Jörg Senn-Bilfinger
  • Tricyclic imidazopyridines
    Patent number: 6696461
    Abstract: Compounds of formula (I) in which the substituents as defined in the description are useful for preventing and treating gastrointestinal disorders.
    Type: Grant
    Filed: October 4, 2002
    Date of Patent: February 24, 2004
    Assignee: Altana Pharma AG
    Inventors: Jörg Senn-Bilfinger, Wilm Buhr, Reinhard Huber, Ernst Sturm
  • Tetrahydropyridoethers
    Patent number: 6696460
    Abstract: Compounds of formula (1) in which the substituents have the meanings mentioned in the description, are suitable for the prevention and treatment of gastrointestinal diseases.
    Type: Grant
    Filed: March 25, 2002
    Date of Patent: February 24, 2004
    Assignee: Atlanta Pharma AG
    Inventor: Jörg Senn-Bilfinger